Alan Brooks
Corporate Officer/Principal at METAGENOMI, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Brian Thomas | M | 55 | 8 years | |
Jian Irish | M | 60 | 3 years | |
Jürgen Eckhardt | M | 57 | 4 years | |
Simren Delaney | M | 38 | 4 years | |
Risa Stack | M | 55 | 2 years | |
Sarah Noonberg | M | 56 | 1 years | |
Sebastián Bernales | M | 48 | 4 years | |
Willard Dere | M | 70 | 3 years | |
Luis Borges | M | 62 | 1 years | |
Simon Harnest | M | 37 | 3 years | |
Pamela Wapnick | F | 58 | 1 years | |
Christopher Brown | M | 35 | 1 years | |
Michael Conway | M | 48 | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephen Kennedy | M | 67 |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | - |
Jak Knowles | M | - | 2 years | |
Santhosh Palani | M | 41 | 2 years | |
Andrew Scharenberg | M | - |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | 2 years |
Andrew Levin | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 18 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alan Brooks
- Personal Network